Myelodysplastic syndrome associated with bone marrow fibrosis. 1992

G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
Istituto di Scienze Mediche, University of Milan, Italy.

Bone marrow biopsy (BMB) in myelodysplastic syndrome (MDS) frequently reveals a slight alteration in the reticulin stroma which does not have any clinical significance. However, in a minority of cases, full-blown bone marrow fibrosis (BMF) can be found. Primary MDS patients with BMF show distinct clinico-pathological features and an unfavourable prognosis mainly attributable to complications deriving from pancytopenia and continuous transfusions, while leukemic transformation occurs only rarely. Since BMF may characterize other hematological disorders, primary MDS with BMF should be included in the differential diagnosis particularly with malignant myelofibrosis (MM) and idiopathic myelofibrosis (IMF). Secondary MDS with BMF represent a variety of preleukemic conditions in subjects treated for previous neoplasias. Unlike the primary forms, they do not form a clearcut clinico-pathological entity.

UI MeSH Term Description Entries
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses

Related Publications

G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
October 1992, British journal of haematology,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
February 2011, Haematologica,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
May 2022, Annals of laboratory medicine,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
November 1991, Annals of hematology,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
May 2006, The Journal of molecular diagnostics : JMD,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
August 2010, American journal of hematology,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
May 2020, Clinical lymphoma, myeloma & leukemia,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
January 2016, Internal medicine (Tokyo, Japan),
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
May 2018, British journal of haematology,
G Lambertenghi-Deliliers, and C Annaloro, and A Oriani, and D Soligo
September 1990, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!